• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ABSOLUTE PRO LL SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ABSOLUTE PRO LL SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 1012014-150
Device Problems Material Separation (1562); Difficult to Advance (2920); Material Deformation (2976); Mechanical Jam (2983); Activation Failure (3270); Noise, Audible (3273)
Patient Problems Foreign Body In Patient (2687); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/30/2021
Event Type  malfunction  
Manufacturer Narrative
The device is returning for analysis but has not yet been received.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was to treat a highly calcified occluded right superficial femoral artery.The 6f introducer sheath was inserted with some difficulty due to the tight bifurcation.Then a 5x150mm absolute pro ll was advanced to the lesion, with difficulty due to anatomy.Once deployment initiated, only around 5cm of the stent partially deployed and the thumbwheel was only able to turn 4-5 times before being unable to turn further and hearing a sound of the absolute pro delivery system breaking.The whole system with the partially deployed stent was able to be removed via a long 6f introducer.Once removed, it was unable to be confirmed that the delivery system was broken but it was noted that the stent implant was damaged.Two other absolute pro stents (5x60x135 and 5x150x135) were used to successfully treat the lesion.The physician believes the device broke due to the tight bifurcation, although visually they were unable to confirm it.However, the physician remains uncertain if all of the device was retrieved fully or if a broken piece remains in the patient.A scan was not performed to check for remaining device parts in the anatomy.The patient is doing fine.There was no adverse patient sequela and no clinically significant delay.No additional information was provided.
 
Event Description
It was reported that the procedure was to treat a highly calcified occluded right superficial femoral artery.The 6f introducer sheath was inserted with some difficulty due to the tight bifurcation.Then a 5x150mm absolute pro ll was advanced to the lesion, with difficulty due to anatomy.Once deployment initiated, only around 5cm of the stent partially deployed and the thumbwheel was only able to turn 4-5 times before being unable to turn further and hearing a sound of the absolute pro delivery system breaking.The whole system with the partially deployed stent was able to be removed via a long 6f introducer.Once removed, it was unable to be confirmed that the delivery system was broken but it was noted that the stent implant was damaged.Two other absolute pro stents (5x60x135 and 5x150x135) were used to successfully treat the lesion.The physician believes the device broke due to the tight bifurcation, although visually they were unable to confirm it.However, the physician remains uncertain if all of the device was retrieved fully or if a broken piece remains in the patient.A scan was not performed to check for remaining device parts in the anatomy.The patient is doing fine.There was no adverse patient sequela and no clinically significant delay.Subsequent to the initially filed mdr report, return device analysis confirmed there was no separation; therefore it is confirmed that nothing remains in the patient.
 
Manufacturer Narrative
A visual and functional analysis was performed on the returned device.The activation failure, mechanical jam, noise, and material deformation were confirmed.The difficulty to advance and material separation were not confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents.Based on the information provided, the investigation determined the reported difficulties were due to the circumstances of the procedure.In this case, based on the reported information, it is likely that the anatomical conditions of the tight bifurcation and of the highly calcified occluded vessel induced a constriction and damage in the shaft sheath during the insertion process or during the activation, causing resistance with the thumbwheel, and partial deployment.The noise would likely have resulted from the handle separating while attempting to turn the thumbwheel after it became stuck; causing the internal mechanism to become dislocated.The additional damage to the stent was most likely caused during the removal of the system from the anatomy.The return goods analysis confirmed there was no separation noted on the sess, and therefore no foreign body left in the patient.There is no indication of a product quality issue with respect to manufacture, design, or labeling.B1,b2, h1: type of reportable event changed from serious injury to malfunction.Patient code 2687 removed and 2199 added.
 
Manufacturer Narrative
Although the difficulties encountered appear to be related to procedural circumstances, on may 11th, 2022, abbott determined that a field safety notice (fsn) was required for the absolute pro ll peripheral self-expanding stent system (psess).Abbott has confirmed reports of mechanical locking, stent deployment and partial stent deployment failures, resulting from unintended excessive force used to deploy the stent.To reduce occurrences of deployment failures and associated outcomes, abbott is notifying all users of the potential causes and risks.
 
Event Description
Subsequent to the original filing, on may 11th, 2022, abbott determined that a field safety notice was required for the absolute pro ll peripheral self-expanding stent system (psess).Abbott has confirmed reports of mechanical locking, stent deployment and partial stent deployment failures, resulting from unintended excessive force used to deploy the stent.To reduce occurrences of deployment failures and associated outcomes, abbott is notifying all users of the potential causes and risks.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSOLUTE PRO LL SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key11657231
MDR Text Key245150625
Report Number2024168-2021-03068
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
P110028
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Notification
Type of Report Initial,Followup,Followup
Report Date 05/31/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/13/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2023
Device Catalogue Number1012014-150
Device Lot Number0091461
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/21/2021
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/11/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/14/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
6F INTRODUCER; ZIPWIRE STIFF 260, BOSTON SCIENTIFIC.; 6F INTRODUCER; ZIPWIRE STIFF 260, BOSTON SCIENTIFIC.
Patient Outcome(s) Other;
-
-